Literature DB >> 20838320

Negative pressure wound therapy overlay technique with collagen dressings for nonhealing wounds.

Mary Arnold-Long1, Richard Johnson, LuAnn Reed.   

Abstract

BACKGROUND: Our clinical experience suggests that the effectiveness of negative pressure wound therapy is enhanced by adding collagen alginate to the dressing regimen, applying foam over areas that are undermined or tunneled, and approximating and securing wound edges prior to applying foam. CASES: The use of this combined technique is described in 4 cases, including 2 patients with spinal cord injury and category IV pressure ulcers and 2 patients with extensive postsurgical wounds.
CONCLUSION: Our outcomes demonstrate the feasibility of this technique and suggest that patients with significant wound size benefit from adding collagen alginate to negative pressure wound therapy and by applying foam over areas that are undermined or tunneled and/or approximating and securing wound edges prior to applying foam.

Entities:  

Mesh:

Year:  2010        PMID: 20838320     DOI: 10.1097/WON.0b013e3181eda751

Source DB:  PubMed          Journal:  J Wound Ostomy Continence Nurs        ISSN: 1071-5754            Impact factor:   1.741


  3 in total

1.  Combination therapy of oxidised regenerated cellulose/collagen/silver dressings with negative pressure wound therapy for coverage of exposed critical structures in complex lower-extremity wounds.

Authors:  Mei Ling Loh; Benjamin K L Goh; Yuan Kong; George Varughese; Jia Lin Ng; Zhiwen J Lo; Chong Han Pek
Journal:  Int Wound J       Date:  2020-05-24       Impact factor: 3.315

2.  Synthetic polymeric biomaterials for wound healing: a review.

Authors:  Mariam Mir; Murtaza Najabat Ali; Afifa Barakullah; Ayesha Gulzar; Munam Arshad; Shizza Fatima; Maliha Asad
Journal:  Prog Biomater       Date:  2018-02-14

3.  A Comparison of the Biomechanical Performance of 3 Negative Pressure Wound Therapy Foams.

Authors:  Daniel J Gibson
Journal:  J Wound Ostomy Continence Nurs       Date:  2022 Jan-Feb 01       Impact factor: 1.970

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.